Skip to main content
27 February 2021
Last updated:
Friday 26 February 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
  • Contact Us

Strategy

Purespring to develop gene therapies for the kidney

Saturday 13 February 2021
Interviewee/Contributor
Richard Francis
Organisation
Purespring Therapeutics Ltd
Gene therapy
Strategy
  • Read more about Purespring to develop gene therapies for the kidney

Forbion to create and grow biotech companies

Saturday 16 January 2021
Interviewee/Contributor
Sander Slootweg and Juliette Audet
Organisation
Forbion
Commentary
Finance
Strategy
  • Read more about Forbion to create and grow biotech companies

Real world evidence is changing regulatory policy

Sunday 22 November 2020
Interviewee/Contributor
Marie Manley and Zina Chatzidimitriadou
Organisation
Sidley Austin LLP
Clinical trials
Policy & Regulation
Strategy
  • Read more about Real world evidence is changing regulatory policy

New treatments for amyotrophic lateral sclerosis

Sunday 22 November 2020
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
Pharma
Strategy
  • Read more about New treatments for amyotrophic lateral sclerosis

Using wastewater surveillance to control Covid-19

Sunday 22 November 2020
Interviewee/Contributor
Gerard Brandon
Organisation
DeepVerge Plc
Academic Research
Strategy
  • Read more about Using wastewater surveillance to control Covid-19

Transatlantic partnerships in life science

Saturday 17 October 2020
Interviewee/Contributor
Olivier Litzka
Organisation
Andera Partners
Commentary
Finance
Strategy
Venture Capital
  • Read more about Transatlantic partnerships in life science

The role of oncolytic viruses in immuno-oncology

Sunday 13 September 2020
Interviewee/Contributor
Bernard Huber and Paul Higham
Organisation
Oryx GmbH & Co KG and Valo Therapeutics Ltd
Drug discovery
Strategy
Oncolytic viruses
  • Read more about The role of oncolytic viruses in immuno-oncology

Establishing a new role for real world evidence

Sunday 21 June 2020
Interviewee/Contributor
Tara Raveendran
Organisation
Shore Capital Ltd
Policy & Regulation
Strategy
  • Read more about Establishing a new role for real world evidence

The role of base and prime editing in therapeutics

Sunday 21 June 2020
Interviewee/Contributor
Jonathan Frampton
Organisation
Horizon Discovery Group Plc
Gene therapy
Regenerative medicine (Stem cells)
Strategy
  • Read more about The role of base and prime editing in therapeutics

The race to develop a COVID-19 vaccine

Saturday 23 May 2020
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
Strategy
Vaccine
Viral vector
  • Read more about The race to develop a COVID-19 vaccine

Pagination

  • Page 1
  • Next page ››
Subscribe to Strategy

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Microbiotica expands management team
Wednesday February 10 2021
Philippe Dro joins Scenic Biotech as independent chairman
Wednesday February 10 2021
NOXXON announces senior appointment to its new advisory board
Wednesday February 10 2021
Wendy Levin joins Biofidelity as chief medical officer
Wednesday February 10 2021
VarmX appoints Gerard Short as chief medical officer
Wednesday February 10 2021

© 2021 Evernow Publishing Ltd. Powered by Drupal.